EX-FILING FEES 4 d640412dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

Ikena Oncology, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               
Security Type   Security
Class
Title		   Fee
Calculation
Rule		   Amount
Registered (1)		   Proposed
Maximum
Offering
Price Per
Unit		   Maximum
Aggregate
Offering Price		   Fee
Rate		   Amount of
Registration
Fee
               
Equity   Common Stock, $0.001 par value per share   Other (2)   1,930,324 (3)   $1.60   $3,088,518.40   $0.00014760   $455.87
         
Total Offering Amounts     $3,088,518.40     —
         
Total Fees Previously Paid         —
         
Total Fee Offsets         —
         
Net Fee Due               $455.87

 

(1)

In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without the receipt of consideration which results in an increase in the number of the outstanding shares of the Registrant’s common stock, $0.001 par value per share (“Common Stock”).

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The price per share and aggregate offering price are calculated on the basis of $1.60, the average of the high and low price of the Registrant’s Common Stock as reported on the Nasdaq Global Market on March 8, 2024.

(3)

Consists of 1,930,324 additional shares issuable under the Registrant’s 2021 Stock Option and Incentive Plan (the “2021 Plan”), which represents the automatic annual increase to the number of shares available for issuance under the 2021 Plan, effective as of January 1, 2024. Shares available for issuance under the 2021 Plan were previously registered on registration statements on Form S-8 (File No. 333-254858, File No. 333-263640 and File No. 333-270518) filed with the Securities and Exchange Commission on March 30, 2021, March 17, 2022 and March 14, 2023, respectively.